4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-23-000089
SVP Corporate Strategy-Develop sold 2,303 shares at $115.00 ($264,845)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent SVP Corporate Strategy-Develop | 2023-03-16 | Sale | −2,303 | $115.00 | $264,845 | 33,569 | D: show line 1 in the form |
| Open-market sales · 2,303 sh · avg $115.00 · $264,845 | |||||||
Loading xslF345X03/edgardoc.xml…